LENZ Therapeutics, Inc.LENZNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-11.99%
↑ 90% above average
Average (22q)
-119.95%
Historical baseline
Range
High:68.98%
Low:-1777.54%
Volatility
-1539.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -11.99% |
| Q2 2025 | -2.00% |
| Q1 2025 | -15.55% |
| Q4 2024 | -23.86% |
| Q3 2024 | 0.38% |
| Q2 2024 | 38.41% |
| Q1 2024 | 29.73% |
| Q4 2023 | -25.49% |
| Q3 2023 | -28.21% |
| Q2 2023 | -16.23% |
| Q1 2023 | -34.37% |
| Q4 2022 | 61.80% |
| Q3 2022 | 7.42% |
| Q2 2022 | -1.97% |
| Q1 2022 | -38.11% |
| Q4 2021 | -29.73% |
| Q3 2021 | 16.76% |
| Q2 2021 | 11.06% |
| Q1 2021 | 68.98% |
| Q4 2020 | -1777.54% |
| Q3 2020 | -157.93% |
| Q2 2020 | -830.50% |
| Q1 2020 | 0.00% |